This study evaluated the effect of sleep posture on oral appliance therapy to elucidate the interindividual difference of response to the device. Seventy-two unselected patients with sleep apnea syndrome were studied polysomnographically before and after insertion of the individually fabricated and adjusted device. Sleep positions were measured using a body position sensor. The patients were classified into three groups; supine, lateral and prone groups, according to the position in which apneas were most frequently observed. N/A N/A N/A The mean apnea-hypopnea index (AHI) of all patients before treatment [43.0±25.6 (SD)] was significantly (p<0.0001) decreased after insertion of the appliance (21.6±18.3). The device decreased the mean AHI significantly from 29.8 to 11.3 in the supine position and 5.5 to 1.6 in the prone position, and increased, but not significantly, from 7.7 to 8.7 in the lateral posture. The supine (n=44) and prone (n=13) groups showed significant reduction of AHI with the oral appliance, while the lateral group (n=15) revealed only a slight decrease, although not significantly. Responders defined by AHI<10 accounted for 61.4% in the supine group, 0% in the lateral group and 84.6 % in the prone group. Responders defined by a 50% drop in AHI accounted for 84.1%, 6.7%, and 46.7%, respectively. The effectiveness of oral appliance therapy is greatly influenced by sleep posture. Sleep posture recorded by polysomnography may be useful to predict the future success or failure of the device.

Various movement disorders, such as oromandibular dystonia, oral dyskinesia, bruxism, functional (psychogenic) movement disorder, and tremors, exist in the stomatognathic system. Most patients experiencing involuntary movements due to these disorders visit dentists or oral surgeons, who may be the first healthcare providers. However, differential diagnoses require neurological and dental knowledge. This study aimed to review scientific advances in botulinum toxin therapy for these conditions. The results indicated that botulinum toxin injection is effective and safe, with few side effects in most cases when properly administered by an experienced clinician. The diagnosis and treatment of movement disorders in the stomatognathic system require both neurological and dental or oral surgical knowledge and skills, and well-designed multicenter trials with a multidisciplinary team approach must be necessary to ensure accurate diagnosis and proper treatment.

Lingual dystonia is a debilitating type of oromandibular dystonia characterized by involuntary, often task-specific, contractions of the tongue muscle activated by speaking or eating. Botulinum neurotoxin (BoNT) has been used to treat lingual dystonia; however, it is known to cause serious complications, such as dysphagia and aspiration. The purpose of this study was to evaluate the efficacy and adverse effects of individualized BoNT therapy for lingual dystonia. One-hundred-and-seventy-two patients (102 females and 70 males, mean age: 46.2 years) with lingual dystonia were classified into four subtypes based on symptoms of involuntary tongue movements: protrusion (68.6%), retraction (16.9%), curling (7.6%), and laterotrusion (7.0%). Patients were treated with BoNT injection into the genioglossus and/or intrinsic muscles via individualized submandibular and/or intraoral routes. Results were compared before and after BoNT therapy. Botulinum neurotoxin was injected in 136 patients (mean: 4.8 injections). Clinical sub-scores (mastication, speech, pain, and discomfort) in a disease-specific rating scale were reduced significantly (p < 0.001) after administration. Comprehensive improvement after BoNT injection, assessed using the rating scale, was 77.6%. The curling type (81.9%) showed the greatest improvement, while the retraction type showed the least improvement (67.9%). Mild and transient dysphagia occurred in 12.5% of patients (3.7% of total injections) but disappeared spontaneously within several days to two weeks. No serious side effects were observed. With careful diagnosis of subtypes and a detailed understanding of lingual muscle anatomy, individualized BoNT injection into dystonic lingual muscles can be effective and safe.